Pharmaceutical product cross-contamination: industrial and clinical pharmacy practice | Zendy

E Mathia | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Pharmaceutical product cross-contamination: industrial and clinical pharmacy practice

Author(s) -

E Mathia

Publication year - 2013

Publication title -

dar es salaam medical students journal

Language(s) - English

Resource type - Journals

ISSN - 0856-7212

DOI - 10.4314/dmsj.v19i2.5

Subject(s) - pharmacy , product (mathematics) , tanzania , pharmaceutical care , contamination , medicine , health care , intensive care medicine , business , risk analysis (engineering) , family medicine , environmental planning , environmental science , economic growth , ecology , geometry , mathematics , biology , economics

Therapeutic consultation by patients is made complete by drug management which is expected to solve the patients’ problems. Pharmaceutical product cross-contamination is a serious problem which has been detected as an obstacle towards successful therapeutic goals. In the pharmaceutical care of patients in developed countries, cross-contamination of drugs has been well addressed and controlled unlike in most developing countries including Tanzania. This review intends to provide insight into this problem, aiming at increasing awareness on the health impacts of crosscontamination on patients in order to promote preventive strategies employed in combating cross-contamination in both industrial and clinical pharmacy practice.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research